UPDATE 1-Merck immunotherapy appears effective in head and neck cancer-study
May 29, 2015 at 14:35 PM EDT
May 29 (Reuters) - A Merck & Co drug that helps the immune system fight cancer was about twice as effective as the current standard therapy for patients with recurrent or advanced head and neck cancers, according to study data released on Friday.